This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 May;34 Suppl 2(Suppl 2):S330-4.

doi: 10.2337/dc11-s242.

Limitations and future treatment options in type 2 diabetes with renal impairment

Eberhard Ritz¹

Affiliations

PMID: 21525478
PMCID: PMC3632202
DOI: 10.2337/dc11-s242

Review

Limitations and future treatment options in type 2 diabetes with renal impairment

Eberhard Ritz. Diabetes Care. 2011 May.

. 2011 May;34 Suppl 2(Suppl 2):S330-4.

doi: 10.2337/dc11-s242.

Author

Eberhard Ritz¹

Affiliation

¹ Department of Internal Medicine, Nierenzentrum, Im Neuenheimer Feld, Heidelberg, Germany. prof.e.ritz@t-online.de

PMID: 21525478
PMCID: PMC3632202
DOI: 10.2337/dc11-s242

No abstract available

PubMed Disclaimer

Similar articles

Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
Eder S, Leierer J, Kerschbaum J, Rosivall L, Wiecek A, de Zeeuw D, Mark PB, Heinze G, Rossing P, Heerspink HL, Mayer G. Eder S, et al. Diab Vasc Dis Res. 2019 Jan;16(1):47-56. doi: 10.1177/1479164118795559. Epub 2018 Sep 21. Diab Vasc Dis Res. 2019. PMID: 30238781
Angiotensin blockade in type 2 diabetic renal disease.
Ruilope LM, Luño J. Ruilope LM, et al. Kidney Int Suppl. 2002 Dec;(82):S61-3. doi: 10.1046/j.1523-1755.62.s82.12.x. Kidney Int Suppl. 2002. PMID: 12410857 Review.
Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R. Bilous R. Prim Care Diabetes. 2008 Dec;2(4):201-2. doi: 10.1016/j.pcd.2008.06.002. Epub 2008 Aug 28. Prim Care Diabetes. 2008. PMID: 18760685 No abstract available.
[Inhibition of the renin-angiotensin system in type 2 diabetes. New significant results concerning type 2 diabetes and renal disease].
Mogensen CE. Mogensen CE. Ugeskr Laeger. 2001 Oct 1;163(40):5488. Ugeskr Laeger. 2001. PMID: 11601112 Danish. No abstract available.
Current update in the management of diabetic nephropathy.
Van Buren PN, Toto R. Van Buren PN, et al. Curr Diabetes Rev. 2013 Jan 1;9(1):62-77. Curr Diabetes Rev. 2013. PMID: 23167665 Review.

See all similar articles

Cited by

Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
Kothny W, Lukashevich V, Foley JE, Rendell MS, Schweizer A. Kothny W, et al. Diabetologia. 2015 Sep;58(9):2020-6. doi: 10.1007/s00125-015-3655-z. Epub 2015 Jun 12. Diabetologia. 2015. PMID: 26067186 Free PMC article. Clinical Trial.
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.
McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ. McGill JB, et al. Diabetes Care. 2013 Feb;36(2):237-44. doi: 10.2337/dc12-0706. Epub 2012 Oct 1. Diabetes Care. 2013. PMID: 23033241 Free PMC article. Clinical Trial.
Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O, Milon M, Virsolvy A, Hénique C, Schmitt A, Massé JM, Kotelevtsev Y, Yanagisawa M, Webb DJ, Richard S, Tharaux PL. Lenoir O, et al. J Am Soc Nephrol. 2014 May;25(5):1050-62. doi: 10.1681/ASN.2013020195. Epub 2014 Apr 10. J Am Soc Nephrol. 2014. PMID: 24722437 Free PMC article.
Diabetic nephropathy.
Wylie EC, Satchell SC. Wylie EC, et al. Clin Med (Lond). 2012 Oct;12(5):480-2; quiz 483-5. doi: 10.7861/clinmedicine.12-5-480. Clin Med (Lond). 2012. PMID: 23101153 Free PMC article. No abstract available.
Evaluation of Effect of Montelukast in the Model of Streptozotocin Induced Diabetic Nephropathy in Rats.
Kokate D, Marathe P. Kokate D, et al. Indian J Endocrinol Metab. 2024 Jan-Feb;28(1):47-54. doi: 10.4103/ijem.ijem_414_22. Epub 2024 Feb 26. Indian J Endocrinol Metab. 2024. PMID: 38533280 Free PMC article.

See all "Cited by" articles

References

1. Gansevoort RT, Ritz E. Hermann Senator and albuminuria: forgotten pioneering work in the 19th century. Nephrol Dial Transplant 2009;24:1057–1062 - PubMed
1. Schmitz R. Ueber die prognostische Bedeutung und die Aetiologie der Albuminurie bei Diabetes. Berliner Klinische Wochenschrift 1891;28:373–377
1. Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999;34:795–808 - PubMed
1. Schwenger V, Müssig C, Hergesell O, Zeier M, Ritz E. Incidence and clinical characteristics of renal insufficiency in diabetic patients. Dtsch Med Wochenschr 2001;126:1322–1326 - PubMed
1. Sørensen VR, Hansen PM, Heaf J, Feldt-Rasmussen B. Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int 2006;70:187–191 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information